Jr. Dowd et al., WOMEN WITH A PELVIC MASS - WHEN TO PERFORM AN ULTRASOUND, Australian and New Zealand Journal of Obstetrics and Gynaecology, 33(4), 1993, pp. 404-407
A retrospective study of 264 patients with a pelvic mass who had a pre
operative serum CA 125 level performed was undertaken to compare the s
ensitivity, specificity and predictive values of this test as a predic
tor of malignancy, compared with clinical impression and ultrasonograp
hy (USG). The values were calculated for each parameter alone and in c
ombination, and the effect of menopausal status, histological type and
stage of disease was also assessed. The results indicate that in post
menopausal women with a pelvic mass, a CA 125 level should be performe
d and the patient referred to a gynaecological oncologist if the value
is raised. In contrast both CA 125 and USG should be performed in the
premenopausal woman to allow appropriate referral. In this study a CA
125 level of 35 u/ml or more correctly identified malignancy in 90% o
f postmenopausal women.